Jan Demol

841 total citations
21 papers, 603 citations indexed

About

Jan Demol is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Jan Demol has authored 21 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Biomedical Engineering. Recurrent topics in Jan Demol's work include Orthopaedic implants and arthroplasty (3 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Cancer Treatment Studies (3 papers). Jan Demol is often cited by papers focused on Orthopaedic implants and arthroplasty (3 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Cancer Treatment Studies (3 papers). Jan Demol collaborates with scholars based in Belgium, Italy and France. Jan Demol's co-authors include S. M. Kumta, K.C. Wong, Jan Dijkmans, Shuigen Huang, Yiannis Pontikes, Kristof Houthoofd, Bert F. Sels, Hans Van Oosterwyck, Frederik Gelaude and Jan Schrooten and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Jan Demol

21 papers receiving 592 citations

Peers

Jan Demol

SURGE

ONCOL

PRM

Shaihong Zhu China

Xiangtian Deng China

Xuzhuo Chen China

Xigao Cheng China

Xingzhi Zhou China

Hao‐Ji Wei Taiwan

Guohui Wang China

Zhimin Ye China

Jiachen Sun China

Guiqin Song China

Shaihong Zhu China

Jan Demol

231 ×1.0

242 ×1.2

SURGE

164 ×1.1

ONCOL

66 ×0.6

PRM

94 ×1.0

Citations per year, relative to Jan Demol Jan Demol (= 1×) peers Shaihong Zhu

Countries citing papers authored by Jan Demol

Since Specialization

Citations

This map shows the geographic impact of Jan Demol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Demol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Demol more than expected).

Fields of papers citing papers by Jan Demol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Demol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Demol. The network helps show where Jan Demol may publish in the future.

Co-authorship network of co-authors of Jan Demol

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Demol. A scholar is included among the top collaborators of Jan Demol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Demol. Jan Demol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martens, Geert A., Jan Demol, Franceska Dedeurwaerdere, et al.. (2024). Surveillance of Disease Progression in Metastatic Breast Cancer by Molecular Counting of Circulating Tumor DNA Using Plasma-SeqSensei Breast Cancer in Vitro Diagnostics Assay. Journal of Molecular Diagnostics. 27(1). 25–35. 3 indexed citations

Martens, Geert A., Jan Demol, Franceska Dedeurwaerdere, et al.. (2024). Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer. ESMO Open. 9(2). 102235–102235. 9 indexed citations

Gelaude, Frederik, et al.. (2018). CT-based quantification of bone loss for refined classification of acetabular deficiencies: comparison of 30 Paprosky type IIIA-B cases. 2 indexed citations

Demol, Jan, et al.. (2016). Virtual anatomical reconstruction of large acetabular bone defects using a statistical shape model. Computer Methods in Biomechanics & Biomedical Engineering. 20(6). 577–586. 29 indexed citations

Demol, Jan, et al.. (2016). Abscopal effect in metastatic renal cell carcinoma. Acta Clinica Belgica. 72(4). 245–249. 19 indexed citations

Wong, K.C., et al.. (2015). One-step reconstruction with a 3D-printed, biomechanically evaluated custom implant after complex pelvic tumor resection. Computer Aided Surgery. 20(1). 14–23. 186 indexed citations

Dijkmans, Jan, Jan Demol, Kristof Houthoofd, et al.. (2015). Post-synthesis Snβ: An exploration of synthesis parameters and catalysis. Journal of Catalysis. 330. 545–557. 90 indexed citations

Demol, Jan, et al.. (2014). Computed tomography-based joint locations affect calculation of joint moments during gait when compared to scaling approaches. Computer Methods in Biomechanics & Biomedical Engineering. 18(11). 1238–1251. 17 indexed citations

Demol, Jan, et al.. (2013). 3D printed titanium structures as bone augments: preclinical evaluation of in vivo bone ingrowth. Journal of Bone and Joint Surgery-british Volume. 175–175. 1 indexed citations

10.

Demol, Jan, et al.. (2012). Modelling the effect of repositioning on the evolution of skeletal muscle damage in deep tissue injury. Biomechanics and Modeling in Mechanobiology. 12(2). 267–279. 6 indexed citations

11.

Demol, Jan, et al.. (2012). Bone ingrowth and biological fixation of selective laser melted porous scaffolds for the reconstruction of severe bone defects. 3 indexed citations

12.

Demol, Jan, et al.. (2011). Does tranexamic acid stabilised fibrin support the osteogenic differentiation of human periosteum derived cells?. European Cells and Materials. 21. 272–285. 18 indexed citations

13.

Demol, Jan, Dennis Lambrechts, Liesbet Geris, Jan Schrooten, & Hans Van Oosterwyck. (2010). Towards a quantitative understanding of oxygen tension and cell density evolution in fibrin hydrogels. Biomaterials. 32(1). 107–118. 50 indexed citations

14.

Azambuja, Evandro de, Worta McCaskill‐Stevens, Prudence A. Francis, et al.. (2009). The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Research and Treatment. 119(1). 145–153. 128 indexed citations

15.

Muraru, Luiza, Siegfried Jaecques, Jan Demol, I. Naert, & J. Vander Sloten. (2006). Validation of image-enhanced in vivo microCT based FE models by strain gauge measurements. Journal of Biomechanics. 39. S428–S428. 1 indexed citations

16.

Willemse, Pax H.B., Roberto Sorio, Anne Floquet, et al.. (2004). A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer. Investigational New Drugs. 23(1). 85–89. 10 indexed citations

17.

Giuliani, Rosa, Marianne Paesmans, Jean-Yves Leroy, et al.. (2004). Is age a risk factor of congestive heart failure (CHF) in patients receiving trastuzumab (H)? Results from two Belgian compassionate use programs in metastatic breast cancer (MBC) patients (pts). Journal of Clinical Oncology. 22(14_suppl). 838–838. 4 indexed citations

18.

Giuliani, Rosa, M Paesmans, Jean-Yves Leroy, et al.. (2004). Is age a risk factor of congestive heart failure (CHF) in patients receiving trastuzumab (H)? Results from two Belgian compassionate use programs in metastatic breast cancer (MBC) patients (pts). Journal of Clinical Oncology. 22(14_suppl). 838–838. 2 indexed citations

19.

Cutsem, E. Van, Jean‐Luc Van Laethem, Yves Humblet, et al.. (2001). Phase II study of raltitrexed in combination with oxaliplatin as second line treatment in refractory advanced colorectal cancer. European Journal of Cancer. 37. S273–S273. 2 indexed citations

20.

Verbanck, J., Jan Demol, G. Ghillebert, L Rutgeerts, & I. Surmont. (1993). Ultrasound-guided puncture of the gallbladder for acute cholecystitis. The Lancet. 341(8853). 1132–1133. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact